Axel Becker

5.6k total citations
151 papers, 4.4k citations indexed

About

Axel Becker is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Axel Becker has authored 151 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Cellular and Molecular Neuroscience, 42 papers in Molecular Biology and 20 papers in Physiology. Recurrent topics in Axel Becker's work include Neuroscience and Neuropharmacology Research (58 papers), Neuropeptides and Animal Physiology (23 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Axel Becker is often cited by papers focused on Neuroscience and Neuropharmacology Research (58 papers), Neuropeptides and Animal Physiology (23 papers) and Neurotransmitter Receptor Influence on Behavior (21 papers). Axel Becker collaborates with scholars based in Germany, Nigeria and United States. Axel Becker's co-authors include Gisela Grecksch, Helmut Schröeder, Volker Höllt, Helmut Schröder, Gerburg Keilhoff, Hans‐Gert Bernstein, G. Grecksch, Gerald Wolf, Gerald Huether and Brigitte Peters and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Circulation Research.

In The Last Decade

Axel Becker

147 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Becker Germany 35 2.3k 1.3k 680 486 466 151 4.4k
Yukio Ago Japan 36 1.9k 0.8× 1.5k 1.1× 908 1.3× 556 1.1× 342 0.7× 177 4.3k
Paul Moser France 28 1.8k 0.8× 1.2k 0.9× 506 0.7× 420 0.9× 503 1.1× 71 3.5k
Anna Pittaluga Italy 39 2.7k 1.2× 2.0k 1.5× 510 0.8× 586 1.2× 539 1.2× 155 4.5k
Samuel S. Newton United States 36 1.8k 0.8× 1.3k 1.0× 535 0.8× 1.0k 2.1× 455 1.0× 79 4.6k
M. Margarita Behrens United States 31 2.6k 1.1× 2.5k 1.9× 873 1.3× 888 1.8× 667 1.4× 51 6.0k
James Doherty United States 30 1.7k 0.7× 1.4k 1.0× 527 0.8× 518 1.1× 207 0.4× 67 3.7k
Michael O. Poulter Canada 33 1.7k 0.7× 1.3k 1.0× 481 0.7× 810 1.7× 301 0.6× 73 3.8k
Bruce Ladenheim United States 41 2.9k 1.3× 2.1k 1.6× 410 0.6× 448 0.9× 656 1.4× 97 5.2k
Subhash C. Pandey United States 47 3.0k 1.3× 2.9k 2.2× 750 1.1× 615 1.3× 801 1.7× 177 6.8k

Countries citing papers authored by Axel Becker

Since Specialization
Citations

This map shows the geographic impact of Axel Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Becker more than expected).

Fields of papers citing papers by Axel Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Becker. The network helps show where Axel Becker may publish in the future.

Co-authorship network of co-authors of Axel Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Becker. A scholar is included among the top collaborators of Axel Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Becker. Axel Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Becker, Axel. (2023). API co-crystals – Trends in CMC-related aspects of pharmaceutical development beyond solubility. Drug Discovery Today. 28(5). 103527–103527. 8 indexed citations
3.
Becker, Axel, et al.. (2022). Influence of COVID-19 on air travel - A scenario study toward future trusted aviation. Journal of Air Transport Management. 106. 102325–102325. 16 indexed citations
4.
Kaushik, Rahul, et al.. (2020). Fine structure analysis of perineuronal nets in the ketamine model of schizophrenia. European Journal of Neuroscience. 53(12). 3988–4004. 28 indexed citations
6.
Chindo, Ben A., Helmut Schröder, & Axel Becker. (2014). Methanol extract of Ficus platyphylla ameliorates seizure severity, cognitive deficit and neuronal cell loss in pentylenetetrazole-kindled mice. Phytomedicine. 22(1). 86–93. 23 indexed citations
7.
Becker, Axel, et al.. (2014). The anxiolytic effects of a Valerian extract is based on Valerenic acid. BMC Complementary and Alternative Medicine. 14(1). 267–267. 48 indexed citations
8.
Miraghaee, Shahram, Isaac Karimi, & Axel Becker. (2011). Psychobiological Assessment of Smoke of Agarwood (Aquilaria spp.) in Male Rats. DergiPark (Istanbul University). 6 indexed citations
9.
Grecksch, Gisela, Laura Glück, Christian Doll, et al.. (2011). Analgesic Tolerance to High-Efficacy Agonists But Not to Morphine Is Diminished in Phosphorylation-Deficient S375A μ-Opioid Receptor Knock-In Mice. Journal of Neuroscience. 31(39). 13890–13896. 49 indexed citations
10.
Becker, Axel, Gisela Grecksch, Herbert Schwegler, & Thomas Roskoden. (2008). Expression of mRNA of Neurotrophic Factors and their Receptors are Significantly Altered After Subchronic Ketamine Treatment. Medicinal Chemistry. 4(3). 256–263. 16 indexed citations
11.
Becker, Axel, et al.. (2008). Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia. Psychopharmacology. 202(4). 579–587. 19 indexed citations
12.
Becker, Axel, et al.. (2006). Handbuch MaRisk : Mindestanforderungen an das Risikomanagement in der Bankpraxis. 1 indexed citations
13.
Keilhoff, Gerburg, Axel Becker, Gisela Grecksch, Hans‐Gert Bernstein, & Gerald Wolf. (2005). Cell Proliferation is Influenced by Bulbectomy and Normalized by Imipramine Treatment in a Region-Specific Manner. Neuropsychopharmacology. 31(6). 1165–1176. 88 indexed citations
14.
Becker, Axel, et al.. (2005). Praktiker-Handbuch Basel II : Kreditrisiko, operationelles Risiko, Überwachung, Offenlegung. Schäffer-Poeschel eBooks. 1 indexed citations
15.
Becker, Axel, et al.. (2000). Pentylenetetrazol-kindling Modulates Stimulated Dopamine Release in the Nucleus Accumbens of Rats. Pharmacology Biochemistry and Behavior. 66(2). 425–428. 35 indexed citations
16.
Becker, Axel. (1997). Differences Between Two Substrains of AB Mice in the Opioid System. Pharmacology Biochemistry and Behavior. 58(3). 763–766. 10 indexed citations
17.
Becker, Axel, Gisela Grecksch, & Hansjürgen Matthies. (1994). The influence of diazepam on learning processes impaired by pentylenetetrazol kindling. Naunyn-Schmiedeberg s Archives of Pharmacology. 349(5). 492–496. 34 indexed citations
18.
Becker, Axel, et al.. (1991). Pharmacological effects on two inbred substrains of AB mice. Pharmacology Biochemistry and Behavior. 38(2). 471–473. 3 indexed citations
19.
Grecksch, Gisela, et al.. (1991). Gangliosides improve a memory deficit in pentylenetetrazol-kindled rats. Pharmacology Biochemistry and Behavior. 39(3). 825–828. 31 indexed citations
20.
Becker, Axel, et al.. (1989). Avoidance and brightness discrimination conditioning in genetically different lines of rats. Physiology & Behavior. 45(2). 347–350. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026